Key result
Higher neuroticism is linked to ~13% higher cardiometabolic risk per SD over 40 years.
Why the study?
Anxiety is linked to elevated cardiometabolic disease risk, but the underlying mechanisms remain unclear.
Are higher baseline levels of neuroticism and worry prospectively associated with elevated cardiometabolic risk trajectories and greater risk of developing >=6 high-risk cardiometabolic biomarkers over 40 years in initially healthy men?
Cohort (n=1,561)
No
Are higher baseline levels of neuroticism and worry prospectively associated with elevated cardiometabolic risk trajectories and greater risk of developing >=6 high-risk cardiometabolic biomarkers over 40 years in initially healthy men?
Higher neuroticism and worry in middle adulthood are associated with stable, persistent elevations in cardiometabolic risk across 4 decades and a 10% to 13% higher hazard of developing multisystem cardiometabolic dysregulation, suggesting anxiety-related cardiometabolic divergence begins prior to midlife.
Answers are grounded in this paper and cite their sources.
Should not yet guide cardiometabolic risk stratification in men; leaves open whether anxiety-targeted interventions alter long-term biomarker trajectories.
Background Anxiety is linked to elevated risk of cardiometabolic disease onset, but the underlying mechanisms remain unclear. We examined the prospective association of 2 anxiety facets, neuroticism and worry, with cardiometabolic risk (CMR) trajectories for 4 decades. Methods and Results The sample comprised 1561 men from an ongoing adult male cohort. In 1975, healthy men (mean age, 53 years [SD, 8.4 years]) completed the Eysenck Personality Inventory-Short Form neuroticism scale and a Worries Scale. Seven CMR biomarkers were assessed every 3 to 5 years. The CMR score was the number of biomarkers categorized as high-risk based on established cut points or medication use. Using mixed effects regression, we modeled CMR trajectories over age and evaluated their associations with neuroticism and worry. Using Cox regression, we examined associations of neuroticism and worry with risk of having ≥6 CMR high-risk biomarkers through 2015. CMR increased at 0.8 markers per decade from age 33 to 65 years, at which point men had an average of 3.8 high-risk markers, followed by a slower increase of 0.5 markers per decade. Higher neuroticism (B=0.08; 95% CI, 0.02-0.15) and worry levels (B=0.07; 95% CI, 0.001-0.13) were associated with elevated CMR across time, and with 13% (95% CI, 1.03-1.23) and 10% (95% CI, 1.01-1.20) greater risks, respectively, of having ≥6 high-risk CMR markers, adjusting for potential confounders. Conclusions By middle adulthood, higher anxiety levels are associated with stable differences in CMR that are maintained into older ages. Anxious individuals may experience deteriorations in cardiometabolic health earlier in life and remain on a stable trajectory of heightened risk into older ages.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a cohort in Cardiometabolic risk trajectories in initially healthy men (n=1,561). Baseline neuroticism (Eysenck Personality Inventory-Short Form) and worry (Worries Scale) levels vs. Lower baseline levels of neuroticism and worry was evaluated on Risk of having >=6 high-risk cardiometabolic risk (CMR) biomarkers (out of 7: systolic BP, diastolic BP, fasting total cholesterol, fasting triglycerides, BMI, fasting glucose, and ESR) during follow-up (HR 1.13, 95% CI 1.03-1.23). Higher baseline neuroticism and worry were associated with greater risk of developing >=6 high-risk cardiometabolic biomarkers over 40 years of follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: